Meat crust antioxidant defense system for commercial meat products
A novel antioxidant defense system designed for meat products to prevent lipid peroxidation and enhance flavor stabilization. Suitable for the food industry, restaurant chains, and home cooking. The technology is at TRL 5, aiming for commercial scalability.
Overview
The proposed antioxidant defense system represents a breakthrough in meat product preservation by preventing lipid peroxidation, a major cause of chemical spoilage affecting texture, nutritional value, and ultimately human health. This innovative crust solution is applicable across all meat products, offering an enhanced ability to stabilize flavor without altering the original taste. It is designed for use by the food industry, restaurant chains, retailers, and even home cooks, positioning it as a versatile solution for various market segments.
Technical specifications
Key features:
- Compatible with all types of meat products
- Prevents oxidation through a novel crust application
- Enhances flavor stabilization without altering original taste
- Utilizes a scalable process involving a laboratory drum dryer
- Evaluated for stability at various temperatures and packaging conditions
The system involves producing a thin layer of crust using a drum dryer, designed specifically for food, chemical, and pharmaceutical applications. This process can be scaled to produce 1-10 kilograms per day. The crust is tested for antioxidant activity and water content to ensure effectiveness.
Technology readiness level
Currently at Technology Readiness Level 5, the system has undergone validation in laboratory settings. Future plans include process scaling and stability evaluation under different packaging and temperature conditions to further prepare for commercial deployment.
About Hebrew University of Jerusalem
The Hebrew University of Jerusalem is a comprehensive public research university with multiple campuses in Jerusalem and an agricultural campus in Rehovot. Its integration with Hadassah’s university hospitals enables clinical studies, access to varied patient populations, and co‑located research that accelerates translation. Industry engagement runs through Yissum, the university’s tech‑transfer company, managing IP, licensing, startup creation, and sponsored research agreements. Research is supported by competitive national funding and international programs, including European Union frameworks.
delivered to your inbox.